COVID-19 has brought the world to its knees. Countries are at different stages of transmission of the pandemic, trying their best to cope with its growing economic and social impact.

With the addition of more startups every year, India has developed and is witnessing one of the largest startup ecosystems in the world.

The second wave of COVID-19 in India left the country in dismay due to the grim statistics of deaths. India Inc. was seen divided and confused, assessing its responsibility and liability in case of untimely deaths of its employees due to the novel virus.

COVID-19 has posed unprecedented challenges and in many cases business continuity plans are being put to test for the first time.

Coronavirus has taken the world by storm and it is not a new recommendation to stay at home and abide by social distancing as much as possible.

The drug regulator in India has approved two COVID 19 vaccines on a limited and conditional basis.

Amidst the inevitable chaos and compulsive calm due to the prevailing restriction of movement pursuant to the outbreak of the novel coronavirus disease...

The whole world was put down to its knees due to the outbreak of the Covid-19 pandemic in the beginning of 2020. In the wake of such an extreme situation and the difficulties that might be...

FBOs can operate their business temporarily subject to compliance with the FSS Act, 2006 and corresponding Rules and regulations.

The Covid-19 pandemic, a stern and sensitive public health emergency has brought nearly all the countries around the globe to their knees.

This article is part one of a series of three articles that looks at the Supply Chain of the Pharmaceutical industry in the context of the COVID-19 pandemic.

The Supreme Court of India on June 12, 2020 in the matter of Ficus Pax Private Limited v. Union of India passed a set of interim directions for establishments addressing the most crucial issue of...

On 7 April 2020 Singapore passed the COVID-19 (Temporary Measures) Act, 2020 to provide temporary relief to parties who are unable to perform their contractual obligations due to the COVID-19 pandemic, amongst other measures.

While India is in the throes of its battle with the deadly COVID-19, the payments industry has not been far behind in assessing its impact on the sector and taking necessary preventive actions.

This article is part one of a series of three articles that looks at the Supply Chain of the Pharmaceutical industry in the context of the COVID-19 pandemic

In its recent judgment in the case of Jacob Puliyel v Union of India and Others [Writ Petition (Civil) Number 607 of 2021] (Jacob Puliyel), the Supreme Court of India (Court)...

In a recent order passed in Re: Cognizance for extension of limitation the Hon'ble Supreme Court has recalled the suo motu order dated 27 April 2021 that had granted further extension on the limitation period for ...

In the wake of the Novel Coronavirus (COVID-19) outbreak in the country, the motto everyone is practicing these days is called ‘Social Distancing'.

The broad framework of CSR has been provided in Section 135 of the Companies Act, 2013, Schedule VII of the Act and Companies (CSR Policy) Rules, 2014.

The Covid-19 pandemic has pushed the boundaries of adaptability in every sphere imaginable and has invariably led to the increased use of electronic means.